Akcea Therapeutics, Inc. Shareholders' Equity
Akcea Therapeutics, Inc. had Shareholders' Equity of $479.03 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2020-08-05
- 2020-06-30: Stockholders' Equity Attributable to Parent $479.03M.
- 2020-03-31: Stockholders' Equity Attributable to Parent $509.69M.
- 2019-12-31: Stockholders' Equity Attributable to Parent $543.00M.
- 2019-09-30: Stockholders' Equity Attributable to Parent $325.49M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2020-06-30 | $479.03M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $509.69M 10-Q · filed 2020-08-05 | |
| 2019-12-31 | $543.00M 10-Q · filed 2020-08-05 | |
| 2019-09-30 | $325.49M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $368.64M 10-Q · filed 2020-08-05 | |
| 2019-03-31 | $388.86M 10-Q · filed 2020-08-05 | |
| 2018-12-31 | $276.72M 10-Q · filed 2020-08-05 | |
| 2018-09-30 | $281.41M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $290.40M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $146.30M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $167.82M 10-K · filed 2019-03-01 | $179.63M 10-K · filed 2018-02-28 |
| 2017-09-30 | $197.84M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$82.98M 10-Q · filed 2017-08-09 | |
| 2016-12-31 | -$17.75M 8-K · filed 2018-09-18 |